³ÉÈËVRÊÓƵ

Gynecology Presentations

Vulvovaginitis

Dr. Mansour completed a B.Sc. in Human Physiology at ³ÉÈËVRÊÓƵ followed by his MDCM and residency in Obstetrics & Gynaecology in 2009. He subsequently completed a 2-year fellowship in Minimally Invasive Gynecologic Surgery at St. Michael's Hospital and a M. Sc. in Clinical Epidemiology at the University of Toronto. Involved with UGME and PGME, he was Program Director for OBGYN at ³ÉÈËVRÊÓƵ until 2021.

Ìý

Ìý

Learning Objectives:

1. Review the initial presentation and evaluation of "vaginitis" in adult patients
2. Discuss recurrent vaginitis
3. Review the presentation, epidemiology, and management of the main 5 vulvovaginitis: CandidaÌývulvovaginitis, bacterial vaginitis, Trichomoniasis, Chlamydia trachomatis, Neisseria gonorrhoeae
4. Discuss other causes of vaginitis

   ---

   Medical Treatment of Endometriosis

Togas Tulandi is Professor and Chair of the Department of Obstetrics and Gynecology, and Milton Leong Chair in Reproductive Medicine, ³ÉÈËVRÊÓƵ, as well as the Chief of the Department of Obstetrics and Gynecology of the ³ÉÈËVRÊÓƵ Health Centre. Besides medical degrees, Dr. Tulandi has MSc degree in Health Care Management from Harvard University. The author of over 400 articles, 60 book chapters, and 14 books, he is the Editor in Chief of the Journal of Obstetrics and Gynecology Canada. Dr. Tulandi is listed in Best Doctors in Canada. In 2021, he was inducted to the fellowship of the Canadian Academy of Health Sciences, and in 2022, he received Life Time Award of Excellence in Gynecology from the Canadian Society for the Advancement of Gynecologic Excellence.

Learning Objectives:

1. Describe and review medical treatment of endometriosis
2. Describe different treatment of endometriosis
3. Describe when the patients should be referred to endometriosis center

   ---

   Cervical cancer screening and management

Dr. Annie Leung is a gynecologic oncologist at the ³ÉÈËVRÊÓƵ Health Center. She is affiliated with the Departments of Obstetrics and Gynecology, Oncology, and Pathology. In her clinical practice, she treats patients with gynecologic malignancy throughout the cancer journey offering surgery, chemotherapy, targeted therapies, and palliative care. For cervical pre-cancer, she also provides care in colposcopy clinic for patients with abnormal paps and positive HPV results. In her research, she is a Scientist at the Research Institute of the ³ÉÈËVRÊÓƵ Health Center where she leads a translational laboratory investigating biomarkers relevant to cervical pre-cancer and cancer. Specifically, her expertise is in the detection of protein markers and circulating tumor DNA. Her research is funded by the Fonds de Recherche du Quebec – Santé (Junior 1 Clinician Scientist), American Association of Obstetricians and Gynecologist, MUHC Foundation, and Cedars Cancer Foundation.

Learning Objectives:

1. Describe the rationale for primary human papillomavirus testing
2. Management of abnormal screening results
3. Updates in new approaches in cervical cancer treatment

   ---

   Early Detection of Gynecological Cancers

Ìý

Dr. Lucy Gilbert is a Professor at ³ÉÈËVRÊÓƵ where she holds the Robert Kinch Chair in Women’s Health. She is also the Director of Gynecologic Oncology at ³ÉÈËVRÊÓƵ Health.

Ìý

Ìý

Ìý

Learning Objectives:

1. Know more about cancers affecting the female gynecological organs and recognize the burden they pose to society
2. Recognize symptoms and Raise awareness in your patients about the symptom
3. Initiate appropriate investigations
4. Recognize when to refer and to whom